Results 11 to 20 of about 34,041 (224)
Bordetella holmesii, an emerging pathogen, can be misidentified as Bordetella pertussis by routine polymerase chain reaction (PCR). In some reports, up to 29% of the patients diagnosed with pertussis have in fact B.
Laure F Pittet +8 more
doaj +3 more sources
Prevalence of Bordetella pertussis and Bordetella parapertussis in Samples Submitted for RSV Screening [PDF]
BACKGROUND: The clinical presentation of Bordetella pertussis can overlap with that of respiratory syncytial virus (RSV); however, management differs.HYPOTHESIS: First, the prevalence of B.
Walsh, Paul +5 more
doaj +2 more sources
Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. [PDF]
BACKGROUND: Recent pertussis outbreaks have prompted re-examination of post-exposure prophylaxis (PEP) strategies, when immunization is not immediately protective.
Crowcroft, Natasha S +11 more
core +1 more source
ЧУВСТВИТЕЛЬНОСТЬ ШТАММОВ BORDETELLA PERTUSSIS К АНТИБАКТЕРИАЛЬНЫМ ПРЕПАРАТАМ
178 strains of B. pertussis isolated from infected individuals in various regions of Russia from 1948 to 2012 have been studied for their susceptibility to six antibacterial preparations. It has been shown, that B. pertussis strains isolated from 1948 to
Е. Е. Донских +11 more
core +2 more sources
Children with pertussis inform the investigation of other pertussis cases among contacts. [PDF]
BACKGROUND: The number of reported pertussis has increased in the last two decades. However, many cases of pertussis may be underreported or not diagnosed.
Paulo N Baptista +8 more
core +1 more source
Structural and functional specialization of Bordetella pertussis DsbA for pertussis toxin folding. [PDF]
Abstract Disulphide bonds (Dsbs) are essential for the folding, stability, and function of many secreted and membrane‐associated proteins in bacteria. In Gram‐negative species, these bonds are introduced by the Dsb enzyme family, with DsbA acting as the primary thiol oxidase.
Penning S +9 more
europepmc +2 more sources
Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018
International audienceBackground: Bordetella pertussis is the main agent of whooping cough. Vaccination with acellular pertussis vaccines has been largely implemented in high-income countries. These vaccines contain 1 to 5 antigens: pertussis toxin (PT),
Bouchez, Valérie +7 more
core +1 more source
The Culture of Bordetella pertussis [PDF]
SUMMARY: Bordetella pertussis grew profusely and retained its normal minute coccobacillary form when grown under 0.4 mm. of fluid lying on a Cohen & Wheeler agar medium + charcoal. Microbes grown in this way were fully antigenic in terms of the mouse protection test. It was easy to obtain harvests of 1.2 x 1011 organisms/ml.
openaire +2 more sources
Bordetella pertussisand Pertussis Vaccines [PDF]
Bordetella pertussis is a human-specific pathogen that causes whooping cough. The use of pertussis whole-cell vaccines in infants and toddlers led to decreased circulation of the bacterium in the child population and a marked decrease in the incidence of the disease. However, vaccine does not result in life-long immunity; indeed, the circulation of the
openaire +2 more sources
Prior to the COVID-19 pandemic, Bordetella pertussis strains not producing pertactin were globally increasing, especially in countries using the acellular pertussis vaccine. Subsequently, during the pandemic, global pertussis incidence dropped to extreme
Helena Martini +6 more
doaj +1 more source

